Exagen Inc. (XGN)
NASDAQ · Healthcare
Exagen Inc. Operating Income 2018–2025
Exagen Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Exagen Inc. operating income for the quarter ending March 31, 2026 was -3.4 M, a 1.46% increase year-over-year.
- Exagen Inc. operating income for the twelve months ending March 31, 2026 was -12.5 M, a 18.36% decrease year-over-year.
- Exagen Inc. annual operating income for 2025 was -14.1 M, a 3.18% increase from 2024.
- Exagen Inc. annual operating income for 2024 was -13.6 M, a 40.29% decrease from 2023.
- Exagen Inc. annual operating income for 2023 was -22.8 M, a 50.41% decrease from 2022.
- Exagen Inc. annual operating income for 2022 was -46.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Exagen Inc. Operating Income — FAQ
Exagen Inc. (XGN) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Exagen Inc.'s operating income?
Exagen Inc. (XGN) reported operating income of -$14M for fiscal 2025.
Where can I see XGN's operating income history?
The chart and table above show Exagen Inc.'s operating income by year and by quarter, including the growth rate.